LINZESS® (linaclotide) is indicated in adults for the treatment of both irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC).1
Choose LINZESS, the #1 prescribed branded
treatment for IBS-C and CIC2*
Not an actual patient.
*IQVIA Monthly Total Prescriptions Volume data
as of October 2020. Data are subject to change.2